NCT03169790 2025-02-24QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHLImmunityBio, Inc.Phase 1/2 Withdrawn
NCT00513188 2016-12-15Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin LymphomaUniversity of MiamiPhase NA Withdrawn